Tandem Diabetes Care, Inc. Impairment of Intangible Assets, Finite-lived
Tandem Diabetes Care, Inc. (TNDM) reported Impairment of Intangible Assets, Finite-lived of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2022-11-02
- Tandem Diabetes Care, Inc. impairment of intangible assets, finite-lived for the quarter ending 2022-09-30 was $0.00.
- Tandem Diabetes Care, Inc. impairment of intangible assets, finite-lived for the quarter ending 2022-06-30 was $0.00.
- Tandem Diabetes Care, Inc. impairment of intangible assets, finite-lived for the quarter ending 2022-03-31 was $0.00.
- Tandem Diabetes Care, Inc. impairment of intangible assets, finite-lived for the quarter ending 2021-12-31 was $0.00.
- Tandem Diabetes Care, Inc. impairment of intangible assets, finite-lived for fiscal 2021 was $0.00.
- Tandem Diabetes Care, Inc. impairment of intangible assets, finite-lived for fiscal 2020 was $0.00.
- Tandem Diabetes Care, Inc. impairment of intangible assets, finite-lived for fiscal 2019 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | $0.00 derived: sum of 3 quarters · filed 2022-08-03 | $0.00 derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-05-04 | $0.00 derived: sum of 3 quarters · filed 2022-11-02 | $0.00 derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 derived: sum of 3 quarters · filed 2022-11-02 | $0.00 10-K · filed 2022-02-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-22 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |